Genetic variation and dietary response: Nutrigenetics/nutrigenomics

Asia Pacific Journal of Clinical Nutrition

Volumn 11, Issue SUPPL. 6, 2002, Pages

  Simopoulos, Artemis P ^a  

^a Center for Nutrition Genetics & Health   (United States)

Author keywords

Chronic diseases; Dietary recommendations; Dietary response; Gene expression; Gene nutrient interaction; Genetic variation; Nutrigenetics nutrigenomics

Indexed keywords

CHOLESTEROL; FOLIC ACID; SODIUM;

CARCINOMA; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIET; ETHNIC DIFFERENCE; FOOD BIOTECHNOLOGY; GENE EXPRESSION; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; HEALTH HAZARD; HERITABILITY; HUMAN; HYPERTENSION; NUTRIENT; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; OSTEOPOROSIS; QUALITY OF LIFE;

EID: 0036455860     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-6047.11.s6.3.x     Document Type: Conference Paper

References (120)

1. Simopoulos AP, Childs B, eds. Genetic variation and nutrition. World Rev Nutr Diet 1990; 63: 1-300.
2. Simopoulos AP, Herbert V, Jacobson B. The Healing Diet. New York: Macmillan, 1995.
3. Childs B. Genetic variation and nutrition. Am J Clin Nutr 1988; 48: 1500-1504.
4. Simopoulos AP, Nestel P, eds. Genetic variation and dietary response. World Rev Nutr Diet 1997; 80: 1-171.
5. Scott J. Molecular genetics of common diseases. BMJ 1987; 295: 769-771.
6. Suzuki DT, Griffiths AJF, Miller JH. Lewontin RC. An Introduction to Genetic Analysis. New York: Freeman, 1989.
7. National Heart, Lung and Blood Institute. Report of the Task Force on Research in Atherosclerosis. Washington, DC: US Department of Health and Human Services, 1991.
8. Williams RR. Nature, nurture, and family predisposition. N Engl J Med 1988; 318: 769-771.
9. Mongeau J-G. Heredity and blood pressure. Semin Nephrol 1989; 9: 208-216.
10. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; I: 1452-1455.
11. Hamsten A, Iselius L, de Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987; I: 988-991.
12. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nyguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
13. Bonne-Tamir B, Adam A. Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. New York: Oxford University Press, 1992.
14. Bowman JE, Murray RF. Genetic Variation and Disorders in Peoples of African Origin. Baltimore: Johns Hopkins University Press, 1990.
15. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442-446.
16. Evans DA. In: Kalow W, Goedde HW, Agarwal DP, eds. Ethnic Differences in Reactions to Drugs and Xenobiotics. New York: Liss, 1986, 491.
17. Evans DA, Harmer D, Downham DY, Whibley EJ, Idle JR, Ritchie J, Smith RL. The genetic control of sparteine and debrisoquine in metabolism in man with new methods of analyzing biomodal distributions. J Med Genet 1983; 20: 321-329.
18. Idle JR. Poor metabolizers of debrisoquine reveal their true colours. Lancet 1989; 2: 1097.
19. Wolf CR, Moss JE, Miles JS, Gough AC, Spurr NK. Detection of debrisoquine hydroxylation phenotypes. Lancet 1990; 336: 1452-1453.
20. Goldbourt U, de Faire U, Berg K. Genetic Factors in Coronary Heart Disease. Dordrecht: Kluwer, 1994.
21. Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985; 312: 283-289.
22. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438-463.
23. World Health Organization MONICA project. Registration procedures, event rates and case fatality in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
24. Nora JJ, Berg K, Nora AH. Cardiovascular Diseases. Genetics, Epidemiology, and Prevention. New York: Oxford University Press, 1991.
25. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988; 41: 155-178.
26. Berg K. Genetic variability of risk factors for coronary heart disease (CHD). In: Wahlqvist ML, Truswell AS, Smith R, Nestel PJ, eds. Nutrition in a sustainable environment (IUNS Proceedings). London: Smith-Gordon, 1994; 437-440.
27. Williams RR, Hunt SC. Hasstedt SJ, Hopkins PN, Wu U, Berry TD, Stults BM, Barlow GK, Kuida H. Hypertension: Genetics and nutrition. World Rev Nutr Diet 1990; 63: 116-130.
28. Kobberling J, Tillil H. Genetic and nutritional factors in the etiology and pathogenesis of diabetes mellitus. World Rev Nutr Diet 1990 63; 102-115.
29. Bouchard C. Genetic factors in obesity. Med Clin North Am 1989; 73: 67-81.
30. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
31. Goldman D, Enoch M-A. Genetic epidemiology of ethanol metabolic enzymes. A role for selection. World Rev Nutr Diet 1990; 63: 143-160.
32. Friend S. Cancer. Genetic and nutritional aspects. World Rev Nutr Diet 1990; 63: 131-142.
33. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Green JS, Jass JR, Weber JL, Leach FS et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993; 260: 810-812.
34. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklinl JP, Jarvinen H, Powell SM, Jen J, Hamilton SR et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
35. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
36. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early-onset familial breast cancer to chromosome 17Q21. Science 1990; 250: 1684-1689.
37. Sikora K. Genes, dreams, and cancer. BMJ 1994; 308: 1217-1221.
38. Cheng KC, Loeb LA. Genomic instability and tumor progression. Mechanistic considerations. Adv Cancer Res 1993; 60: 121-156.
39. Kinzler KW, Vogelstein B. Clinical implications of basic research. Cancer therapy meets p53. N Engl J Med 1994; 331: 49-50.
40. National Institutes of Health. National Cancer Institute. Conference on Genetic Predisposition to Cancer. Bethesda, Maryland, USA June 14-15, 1994.
41. Childs B. Genetic individuality and nutrition. World Rev Nutr Diet 1990; 63: 14-24.
42. Childs B. Genetic variability in human nutrition. In: Beers Jr RF, Bassett EG, eds. Nutritional Factors. Modulating Effects on Metabolic Processes. New York: Raven Press, 1981; 7-13.
43. Simopoulos AP, ed. Proceedings of the Symposium on Diet and Gene Interactions, Washington, DC, December 6, 2000. Washington, DC: Center for Nutrition Policy and Promotion, USDA. 2001. http://www.cnpp.usda.gov
44. Simopoulos AP. Diet and gene interactions. Food Technol 1997; 51: 66-69.
45. Simopoulos AP. Genetic variation and nutrition. I. Population differences due to single gene defects and population differences in multifactorial diseases due to polygenic effects. Nutr Today 1995; 30: 157-167.
46. Simopoulos AP. Genetic variation and nutrition. 2. Genetic variation, nutrition and chronic diseases. Nutr Today 1995; 30: 194-206.
47. Beynen AC, Katan MB, Van Zutphen LFM, Hypo- and hyperresponders. Individual differences in the response of serum cholesterol concentration to changes in diet. Adv Lipid Res 1987; 22: 115-171.
48. Miettinen TA, Kensaniemi YA. Cholesterol absorption: Regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr 1989; 49: 629-635.
49. Nestel PJ, Poyser A. Changes in cholesterol synthesis and excretion when cholesterol intake is increased. Metabolism 1976; 25: 1591-1599.
50. Glatz JF, Turner PR, Katan MD, Stalenhoef AF, Lewis B. Hypo- and hyperresponse of serum cholesterol level and low density lipoprotein production and degradation to dietary cholesterol in man. Ann NY Acad Sci 1993; 676: 163-179.
51. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apolipoprotein E phenotype. Lancet 1988; 2: 1261.
52. Dallongeville J. Apolipoprotein E polymorphism and atherosclerosis risk. In: Goldbourt U, de Faire U, Berg K, eds. Genetic Factors in Coronary Heart Disease. Dordrecht: Kluwer, 1994; 289-298.
53. Lopez-Miranda J, Ordovas JM. Mata P, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 1994; 35: 1965-1975.
54. Mahley RW, Weisgraber KH, Innerarity TL, Rall SC. Genetic defects in lipoprotein metabolism: Elevation of atherogenic lipoproteins caused by impaired catabolism. JAMA 1991; 265: 78-83.
55. Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A. Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 1992; 86: 849-857.
56. Uusitupa MIJ, Ruuskanen E, Makinen E, Laitinen J, Toskala E, Kervinen K, Kesaniemi YA. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: Relation to apolipoprotein E phenotype. J Am Coll Nutr 1992; 11: 651-659.
57. McCombs RJ, Marcadis DE, Ellis J, Weinberg RB. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 1994; 331: 706-710.
58. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart J-C, Krauss RM, Rubin EM. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001; 294: 169-173.
59. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu U, Berry TD, Stults BM, Barlow GK, Kuida H. Hypertension. Genetics and nutrition. World Rev Nutr Diet 1990; 63: 116-130.
60. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton RP, Williams CS, Charm A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension. Role of angiotensinogen. Cell 1992; 71: 169-180.
61. Caulfied M, Lavender P, Farrall M, Monroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-1633.
62. Jeunemaitre X, Inoue I, Williams C, Chaarru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo A-P, Hata A, Corvol P, Lalouel J-M. Haplotype of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-1460.
63. Inoue I. Nakajima T. Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T. Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel J-M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786-1797.
64. Hall JE. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381-394.
65. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, Walker WG, Whelton PK, Williams RR. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of hypertension prevention. Phase II. Hypertension 1998; 32: 393-401.
66. Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD. Mortensen RM, Mitchell SR, Contin PR, Kesari M for the DASH collaborative research group. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001; 19: 1949-1956.
67. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995; 267: 679-681.
68. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manuta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-1357.
69. Velazquez A, Bourges H, eds. Genetic Factors in Nutrition. Orlando: Academic Press, 1984.
70. Rucker R, Tinker D. The role of nutrition in gene expression. A fertile field for the application of molecular biology. J Nutr 1986; 116: 177-189.
71. Castro CE, Towle HC. Nutrient-genome interaction. Fed Proc 1986; 45: 2382.
72. Berdanier CD, Hargrove JL, eds. Nutrition and Gene Expression. Boca Raton: CRC Press, 1993.
73. Goldstein JL. Genetics and cardiovascular disease, in: Brannwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine, 2nd Edn, Vol. 2. Philadelphia: Saunders, 1984; 1606.
74. Simopoulos AP. Nutrition Policies for the Prevention of Atherosclerosis in Industrialized Societies. In: Moyal MF, ed. Diet and Life Style: New Technology. Paris: Libby, 1988; 373-380.
75. Kang SS, Wong PWWWK, Susman A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary heart disease. Am J Hum Genet 1991; 48: 538-545.
76. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluuijtmans LA, van den Heuvel LP et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
77. De Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P. Spina bifida. 677→C mutation and role of folate. Lancet 1995; 346: 1703.
78. Kirke PN, Mills JL, Whitehead AS, Molloy A, Scott JM. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 1996; 348: 1037-1038.
79. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993; 88: 1463-1469.
80. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142-150.
81. Kluijtmans LAJ, van den Heuval LPW, Boers GHJ, Frosst P, Stevens EM, van Dost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
82. Whiteheard AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weier DG, Shields DC, Scott JM. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88: 763-766.
83. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FT, Eskes TK, van den Heuvel LP, Madman MC, den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
84. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Sstrokosch G. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414-421.
85. Molloy AM, Daly S, Mills JL, Kirke PN, Whitehead AS, Ramsbottom D, Conley MR, Weir DG, Scott JM. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 1997; 349: 1591-1593.
86. Osborn TF, Goldstein JL, Brown MS. 5′-End of HMG-CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription. Cell 1985; 42: 203-212.
87. Clarke SD, Jump DB. Regulation of hepatic gene expression by dietary fats: A unique role for polyunsaturated fatty acids. In: Berdanier DC, Hargrove JL, eds. Nutrition and Gene Expression. Boca Raton: CRC Press, 1993.
88. Clarke SD, Romsos DR, Leveille GA. Differential effects of dietary methylesters of long chain saturated and polyunsaturated fatty acids on rat liver and adipose tissue lipogenesis. J Nutr 1977; 107: 1170-1180.
89. Clarke SD, Armstrong MK, Jump DB. Nutritional control of rat liver fatty acid synthase and S14 mRNA abundance. J Nutr 1990; 120: 218-224.
90. Clarke SD, Jump DB. Polyunsaturated fatty acid regulation of hepatic gene transcription. Lipids 1996; 31 (Suppl.): 7-11.
91. Kaminski WE, Jendraschak C, Kiefl R, von Schacky C. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993; 81: 1871-1879.
92. Robinson DR, Urakaze M, Huang R, Taki H, Sugiyama E, Knoell CT, Xu L, Yeh HT, Auron PE. Dietary marine lipids suppress the continuous expression of interleukin-1B gene transcription. Lipids 1996; 31 (Suppl.): S23-S31.
93. Urakaze M, Sugiyama E, Xu L, Auron P, Yeh E, Robinson D. Dietary marine lipids suppress IL-1B mRNA levels in lipopoly-saccharide stimulated monocytes. Clin Res 1991; 23.
94. Simopoulos AP. The role of fatty acids in gene expression: Health implications. Ann Nutr Metab 1996; 40: 303-311.
95. Ntambi JM. Dietary regulation of stearoyl-CoA desaturase I gene expression in mouse liver. J Biol Chem 1991; 267: 100 925-110 930.
96. DeWillie JW, Farmer SJ. Linoleic acid controls neonatal tissue-specific stearoyl-CoA desaturase mRNA levels. Biochim Biophys Acta 1993; 1170: 291-295.
97. Jump DB, Clarke SD, Thelen A, Liimatta N. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 1994; 35: 1076-1084.
98. Limatta M, Towle HC, Clarke SD, Jump DB. Dietary PUFA interfere with the insulin glucose activation of 1-type pyruvate kinase. Mol Endocrinol 1994; 335: 1076-1684.
99. Tebbey PW, McGowan KM, Stephens JM, Buttke TM, Pekata PH. Arachidonic acid down-regulates the insulin-dependent glucose transporter gene (Glut 4) in 3T3-L 1 adipocytes by inhibiting transcription and enhancing mRNA turnover. J Biol Chem 1994; 269: 639-644.
100. Sellmayer A, Danesch U, Weber PC. Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth. Lipids 1996; 31 (Suppl.): S37-S40.
101. De Caterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996; 31 (Suppl.): S57-S63.
102. Roberts DF. Genetics and nutritional adaptation. In: Blaxter K, Waterlow JC, eds. Nutritional Adaptation in Man. London: Libbey, 1985; 45-59.
103. Gitzelmann R, Baerlocher K. Vorteile und nachteile der fructose in der nahrung. Paediatr Fortbildungsk Prax 1973; 37: 40.
104. Royal College of Physicians. Fractured Neck of Femur. London: Royal College of Physicians, 1989.
105. Eisman JA. Vitamin D receptor gene alleles and osteoporosis: An affirmative view. J Bone Miner Res 1995; 10: 1289-1293.
106. Beavan S, Prentice A, Yan L, Dibba B, Ralston S. Differences in vitamin D receptor genotype and geographical variation in osteoporosis. Lancet 1996; 348: 136-137.
107. Simopoulos AP, Childs B, Committee for the Study of Inborn Errors of Metabolism, Division of Medical Sciences, Assembly of Life Sciences, National Research Council. Genetic Screening, Programs, Principles and Research. Washington, DC: National Academy of Sciences, 1975.
108. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
109. Lander ES. The new genomics. Global views of biology. Science 1996; 274: 536-539.
110. Collins FS, Guyer MS, Chkravarti A. Variations on a theme: Cataloging human DNA sequence variation. Science 1997; 278: 1580-1581.
111. Ruaño G. Haplotypes: The foundation for personalized medicine. Abstract presented at the Genome 2002 Tri-Conference, Santa Clara, California, February 23-March 1, 2002.
112. Simopoulos AP, Kifer RR, Martin RE, Barlow SM. Health effects of ω3 polyunsaturated fatty acids in seafoods. World Rev Nutr Diet 1991; 66: 1-592.
113. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997; 65: 1011-1017.
114. Simopoulos AP. New products from the agri-food industry. The return of n-3 fatty acids into the food supply. Lipids 1999; 34 (Suppl.): S297-S301.
115. Stevens RC, Yokoyama S, Wilson IA. Global efforts in structural genomics. Science 2001; 294: 89-92.
116. Singer PA, Daar AS. Harnessing genomics and biotechnology to improve global health equity. Science 2001; 294: 87-89.
117. Brennan RO. Nutrigenetics. New Concepts for Relieving Hypoglycemia. New York: M Evans Inc, 1975.
118. Anon. National Information Resource on Ethics and Human Genetics. Washington DC: National Reference Center for Bioethics Literature, Kennedy Institute of Ethics, Georgetown University. http://www.georgetown.edu/research/nrcbl/nirehg.htm.
119. Mayor S. UK insurers agree five year ban on using genetic tests. BMJ 2001; 323: 1021.
120. Aker J, ed. The Blue Sheet. Health Policy and Biomedical Research. F-D-C Reports, Chevy Chase, MD. 19 December 2001: 15.